New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2011
08:27 EDTSIGA, PIPPharmAthene, SIGA Technologies should merge, says Roth Capital
Roth Capital believes that the best course of action for PharmAthene(PIP) and SIGA (SIGA) would be to merge, although the firm adds that this isn't necessarily the most likely scenario. The firm thinks that both companies would benefit from a merger and it maintains a $6.25 target and Buy rating on PharmAthene.
News For PIP;SIGA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PIP;SIGA

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use